- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07717229
Effectiveness of BrightHearts Biofeedback Relaxation and Virtual Reality Distraction During Inferior Alveolar Nerve Block Injection in Children
A Comparative Evaluation of the Effectiveness of the BrightHearts Application as a Biofeedback Relaxation Tool Versus Virtual Reality Distraction in Reducing Dental Anxiety and Improving Behavior in Children During Inferior Alveolar Nerve Block Injection: A Randomized Controlled Trial
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sara Ahmed Khira, Bachelor Degree
- Phone Number: 00201012592478
- Email: sara.ahmed28@msa.edu.eg
Study Locations
-
-
-
Giza, Egypt, 12451
- Recruiting
- October University for Modern Science and Arts
-
Contact:
- Naglaa Ibrahim Ezz Eldin, Professor Doctor
- Phone Number: 00201001984184
- Email: niezz@msa.edu.eg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Children from 7 to 12 years
- Children who have dental procedures that require an inferior alveolar nerve block injection.
- Healthy Children.
- Children who fall under Frankl's behavioral rating of 2 (negative) or 3 (positive)
Exclusion Criteria:
- Children with special health care needs
- Children or parents who are unable or unwilling to cooperate with the study protocol or assessment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group A
|
Before the inferior alveolar nerve block procedure, Participants will be taught to use the application after given instructions. They will be asked to keep a constant color by focusing on breathing slowly, then they will be allowed to use the application a few minutes before the inferior alveolar nerve block procedure |
|
Active Comparator: Group B
|
participants in this group will experience Virtual Reality distraction eyewear.
After giving an introduction about it, they will be allowed to accommodate, then they will be wearing it during the inferior alveolar nerve block procedure in an environment designed to distract them during the injection.
The Virtual Reality distraction content will be age-appropriate and engaging, and feature interactive (e.g., Fun animations, and Cartoons).
|
|
Active Comparator: Group C
|
The Verbal distraction method technique involves: patient is given an instruction to do in order to divert his/her attention |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of Dental Anxiety.
Time Frame: - Baseline (5 minutes before injection) - During injection - 2 minutes after injection
|
Using Heart rate monitor.
Heart Rate (beats per minute [bpm]) measured using a heart rate monitor.
Higher heart rate values indicate greater physiological anxiety.
|
- Baseline (5 minutes before injection) - During injection - 2 minutes after injection
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of Dental Anxiety
Time Frame: Baseline (5 minutes before injection)and immediately after injection.
|
Using Facial Image Scale scores range from 1 to 5, with 1 indicating no anxiety (very happy face) and 5 indicating highest anxiety (very unhappy face).
Higher scores indicate greater dental anxiety.
|
Baseline (5 minutes before injection)and immediately after injection.
|
|
Behavior Assessment
Time Frame: During injection
|
FLACC Rating Scale.
Face, Legs, Activity, Cry, Consolability (FLACC) Scale.
Scores range from 0 to 10, with higher scores indicating greater pain and distress.
|
During injection
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- REC-D 22511-5
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.